2130.9000 14.60 (0.69%)
NSE Sep 10, 2025 15:31 PM
Volume: 773.7K
 

ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues grew 19% YoY to | 2224 crore (I-direct estimate: | 2226 crore) mainly due to 29% YoY growth in the US to | 771 crore (Idirect estimate: | 762 crore). India business grew 11% YoY to | 675 crore (I-direct estimate: | 596 crore) EBITDA margins declined 126 bps YoY to 20.2% (vs. I-direct estimate: 20.0%) due to higher other expenditure. EBITDA increased 12% YoY to | 449 crore (I-direct estimate: | 445 crore) Net profit increased 12% YoY to | 224 crore, (I-direct estimate: | 263...
Glenmark Pharmaceuti.. has an average target of 2144.00 from 5 brokers.
More from Glenmark Pharmaceuticals Ltd.
Recommended